\-\ Texto\\:\\ \ \(0\)\
\-\ urine\\ protein\\ 100mg\\/dl\ \(0\)\
\-\ urine\\ creatine\\ 56\\.2mg\\/dl\ \(0\)\
\-\ urine\\ glucose\\ 500mg\\/dl\ \(0\)\
\-\ serum\\ glucose\\ 313mg\\/dl\ \(0\)\
\-\ serum\\ creatine\\ 2\\.9mg\\/dl\ \(0\)\
\-\ patient\\ will\\ undergo\\ survellience\\ imaging\\ to\\ follow\\ lesion\\ size\\.\\ \\ imaging\\ will\\ include\\ ultrasound\\,\\ as\\ she\\ is\\ in\\ chronic\\ renal\\ insufficiency\\ from\\ her\\ dm\\ and\\ actually\\ went\\ into\\ acute\\ renal\\ failure\\ following\\ the\\ current\\ ct\\ exam\\ with\\ contrast\\.\ \(0\)\
\-\ on\\ ultrasound\\,\\ there\\ is\\ a\\ well\\-circumscribed\\,\\ partially\\ exophytic\\,\\ uniformly\\ hyperechoic\\ mass\\ measuring\\ approximately\\ 1\\.8cm\\.\\ \\ there\\ is\\ no\\ visualized\\ internal\\ blood\\ flow\\ on\\ the\\ doppler\\ image\\.\ \(0\)\
\-\ on\\ ct\\,\\ this\\ well\\-circumscribed\\ mass\\ is\\ hetergenously\\ hypodense\\ with\\ respect\\ to\\ renal\\ parenchyma\\.\\ \\ there\\ is\\ macroscopic\\ fat\\ and\\ mildly\\ enhancing\\ internal\\ soft\\ tissue\\ components\\.\\ \\ no\\ calcification\\.\ \(0\)\
\-\ angiomyolipoma\\ \\(sporadic\\)\\,\\ cholelithiasis\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ renal\\ cell\\ carcinoma\\ \\(especially\\ clear\\-cell\\ variant\\)\ \(0\)\
\-\ renal\\ lipoma\ \(1\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 68\\ y\\.o\\.\\ woman\\ with\\ dm\\ type\\ 2\\,\\ on\\ metformin\\;\\ with\\ proteinuria\\.\ \(0\)\
\-\ although\\ the\\ given\\ lesion\\ has\\ a\\ morphology\\ and\\ density\\ characteristics\\ diagnostic\\ of\\ aml\\,\\ there\\ are\\ case\\ reports\\ in\\ the\\ literature\\ of\\ cystic\\/clear\\ cell\\ renal\\ carcinomas\\ having\\ a\\ similar\\ appearance\\.\\ \\ further\\ reassuring\\ is\\ the\\ lack\\ of\\ calcification\\.\\ \\ these\\ lesions\\ should\\ be\\ followed\\,\\ as\\ they\\ can\\ hemorrhage\\ when\\ large\\.\\ \\ the\\ aml\\ is\\ a\\ hamartomatous\\ lesion\\,\\ considered\\ ostensibly\\ benign\\ although\\ sarcomatous\\ degeneration\\ has\\ rarely\\ been\\ known\\ to\\ occur\\.\\ \\ in\\ the\\ vast\\ majority\\ of\\ cases\\,\\ however\\,\\ a\\ renal\\ lesion\\ \\(partially\\ exophytic\\ 25\\%\\ of\\ the\\ time\\)\\ containing\\ macroscopic\\ fat\\,\\ hu\\ \\<\\ \\-60\\,\\ and\\ internal\\ soft\\ tissue\\ components\\ is\\ an\\ aml\\ until\\ proven\\ otherwise\\.\\ \\ there\\ is\\ a\\ 15\\%\\ association\\ with\\ tuberous\\ sclerosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.28494481820330514\ \(0\)\
\-\ aml\\:\\ 0\\.2362177539283412\ \(0\)\
\-\ creatine\\:\\ 0\\.18036332444652073\ \(0\)\
\-\ urine\\:\\ 0\\.17553778619447882\ \(0\)\
\-\ is\\:\\ 0\\.16111284977722673\ \(0\)\
\-\ macroscopic\\:\\ 0\\.14859148321551555\ \(0\)\
\-\ dm\\:\\ 0\\.14625877257744654\ \(0\)\
\-\ exophytic\\:\\ 0\\.1404170146410747\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.13985109603907864\ \(0\)\
\-\ internal\\:\\ 0\\.13216221775299802\ \(0\)\
\-\ there\\:\\ 0\\.13004830813492824\ \(0\)\
\-\ glucose\\:\\ 0\\.1263178586458214\ \(0\)\
\-\ lesion\\:\\ 0\\.12535519119772343\ \(0\)\
\-\ components\\:\\ 0\\.11873952530751944\ \(0\)\
\-\ serum\\:\\ 0\\.11723259980364813\ \(0\)\
\-\ partially\\:\\ 0\\.11220196768166685\ \(0\)\
\-\ cell\\:\\ 0\\.11218025254367046\ \(0\)\
\-\ hetergenously\\:\\ 0\\.10453741063118285\ \(0\)\
\-\ ostensibly\\:\\ 0\\.10453741063118285\ \(0\)\
\-\ the\\:\\ 0\\.1043460251404499\ \(0\)\
\-\ survellience\\:\\ 0\\.09989107670643177\ \(0\)\
\-\ reassuring\\:\\ 0\\.09403738824379125\ \(0\)\
\-\ calcification\\:\\ 0\\.09333949996151356\ \(0\)\
\-\ although\\:\\ 0\\.08900234983280919\ \(0\)\
\-\ metformin\\:\\ 0\\.08865149001568026\ \(0\)\
\-\ hamartomatous\\:\\ 0\\.08730178247392939\ \(0\)\
\-\ sarcomatous\\:\\ 0\\.08609442793603996\ \(0\)\
\-\ will\\:\\ 0\\.08414498446285239\ \(0\)\
\-\ proteinuria\\:\\ 0\\.08308792513651306\ \(0\)\
\-\ fat\\:\\ 0\\.08132566236252695\ \(0\)\
\-\ uniformly\\:\\ 0\\.08070852970792897\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0806401970221561\ \(0\)\
\-\ on\\:\\ 0\\.07896884171308474\ \(0\)\
\-\ vast\\:\\ 0\\.07873925130944708\ \(0\)\
\-\ sporadic\\:\\ 0\\.07429574160775777\ \(0\)\
\-\ respect\\:\\ 0\\.07350513370353756\ \(0\)\
\-\ carcinomas\\:\\ 0\\.07312938628872327\ \(0\)\
\-\ hu\\:\\ 0\\.07276556940017766\ \(0\)\
\-\ actually\\:\\ 0\\.0714158618584268\ \(0\)\
\-\ morphology\\:\\ 0\\.06964940768300668\ \(0\)\
\-\ soft\\:\\ 0\\.06960089656016594\ \(0\)\
\-\ imaging\\:\\ 0\\.06870602676732968\ \(0\)\
\-\ tissue\\:\\ 0\\.06858099351181583\ \(0\)\
\-\ proven\\:\\ 0\\.06595066041107439\ \(0\)\
\-\ cholelithiasis\\:\\ 0\\.06556217339578627\ \(0\)\
\-\ tuberous\\:\\ 0\\.06518642598097198\ \(0\)\
\-\ with\\:\\ 0\\.06399920381163857\ \(0\)\
\-\ of\\:\\ 0\\.06396098713706523\ \(0\)\
\-\ literature\\:\\ 0\\.06379571922036616\ \(0\)\
\-\ went\\:\\ 0\\.0634729015506755\ \(0\)\
\-\ hypodense\\:\\ 0\\.0634729015506755\ \(0\)\
\-\ insufficiency\\:\\ 0\\.06300511131614595\ \(0\)\
\-\ 68\\:\\ 0\\.0628533306939445\ \(0\)\
\-\ undergo\\:\\ 0\\.061043877333189916\ \(0\)\
\-\ degeneration\\:\\ 0\\.060789216420839266\ \(0\)\
\-\ protein\\:\\ 0\\.06066397725681688\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.060176275167675285\ \(0\)\
\-\ characteristics\\:\\ 0\\.05993999319983528\ \(0\)\
\-\ has\\:\\ 0\\.059716251505642096\ \(0\)\
\-\ majority\\:\\ 0\\.05936976265375972\ \(0\)\
\-\ association\\:\\ 0\\.05882656762592441\ \(0\)\
\-\ containing\\:\\ 0\\.058720951491686504\ \(0\)\
\-\ doppler\\:\\ 0\\.05851259539815961\ \(0\)\
\-\ rarely\\:\\ 0\\.058307960148709884\ \(0\)\
\-\ variant\\:\\ 0\\.058007700103323095\ \(0\)\
\-\ current\\:\\ 0\\.057243465673220674\ \(0\)\
\-\ lipoma\\:\\ 0\\.05670198213361886\ \(0\)\
\-\ having\\:\\ 0\\.056354704968097566\ \(0\)\
\-\ lack\\:\\ 0\\.05593490456507088\ \(0\)\
\-\ until\\:\\ 0\\.054394431889879497\ \(0\)\
\-\ and\\:\\ 0\\.05402985735224431\ \(0\)\
\-\ parenchyma\\:\\ 0\\.05310091702543862\ \(0\)\
\-\ mildly\\:\\ 0\\.05278346543847115\ \(0\)\
\-\ as\\:\\ 0\\.052521164449667174\ \(0\)\
\-\ especially\\:\\ 0\\.051708371043346475\ \(0\)\
\-\ visualized\\:\\ 0\\.0510438794334982\ \(0\)\
\-\ considered\\:\\ 0\\.05093678267784264\ \(0\)\
\-\ reports\\:\\ 0\\.05083067757304949\ \(0\)\
\-\ measuring\\:\\ 0\\.050569635090408314\ \(0\)\
\-\ mass\\:\\ 0\\.049937541580893655\ \(0\)\
\-\ diagnostic\\:\\ 0\\.04982039643489426\ \(0\)\
\-\ similar\\:\\ 0\\.04982039643489426\ \(0\)\
\-\ ct\\:\\ 0\\.04977230266113406\ \(0\)\
\-\ failure\\:\\ 0\\.04962860502163104\ \(0\)\
\-\ to\\:\\ 0\\.049025496599745276\ \(0\)\
\-\ in\\:\\ 0\\.04878419320701663\ \(0\)\
\-\ occur\\:\\ 0\\.048074683024314495\ \(0\)\
\-\ they\\:\\ 0\\.04670653739419963\ \(0\)\
\-\ otherwise\\:\\ 0\\.04659652756263761\ \(0\)\
\-\ sclerosis\\:\\ 0\\.04656009106311268\ \(0\)\
\-\ 25\\:\\ 0\\.04630822884889439\ \(0\)\
\-\ given\\:\\ 0\\.04496643243582913\ \(0\)\
\-\ benign\\:\\ 0\\.04490329580533667\ \(0\)\
\-\ size\\:\\ 0\\.044260551493901575\ \(0\)\
\-\ 15\\:\\ 0\\.044171604583321145\ \(0\)\
\-\ followed\\:\\ 0\\.04414210837798545\ \(0\)\
\-\ cases\\:\\ 0\\.04396670797225374\ \(0\)\
\-\ type\\:\\ 0\\.04385124836127091\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.04376541073559518\ \(0\)\
\-\ flow\\:\\ 0\\.043539605016645104\ \(0\)\
\-\ density\\:\\ 0\\.0433456103325685\ \(0\)\
\-\ should\\:\\ 0\\.04265251305616539\ \(0\)\
\-\ further\\:\\ 0\\.0425751723613748\ \(0\)\
\-\ no\\:\\ 0\\.04251375709651308\ \(0\)\
\-\ known\\:\\ 0\\.0423210761536908\ \(0\)\
\-\ image\\:\\ 0\\.041805137657377124\ \(0\)\
\-\ approximately\\:\\ 0\\.04170944382824089\ \(0\)\
\-\ enhancing\\:\\ 0\\.0409490525981765\ \(0\)\
\-\ her\\:\\ 0\\.04083811979142588\ \(0\)\
\-\ when\\:\\ 0\\.0394859592325521\ \(0\)\
\-\ appearance\\:\\ 0\\.039407738659581595\ \(0\)\
\-\ following\\:\\ 0\\.039214491762147086\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03910008878753357\ \(0\)\
\-\ she\\:\\ 0\\.038911919215530916\ \(0\)\
\-\ include\\:\\ 0\\.03889327109189402\ \(0\)\
\-\ chronic\\:\\ 0\\.03880048297807776\ \(0\)\
\-\ time\\:\\ 0\\.03874516861751613\ \(0\)\
\-\ however\\:\\ 0\\.03869011997948688\ \(0\)\
\-\ been\\:\\ 0\\.03808404536157038\ \(0\)\
\-\ blood\\:\\ 0\\.03796314765221102\ \(0\)\
\-\ lesions\\:\\ 0\\.037541493408425664\ \(0\)\
\-\ these\\:\\ 0\\.036913210265525756\ \(0\)\
\-\ metastatic\\:\\ 0\\.03585099158692192\ \(0\)\
\-\ acute\\:\\ 0\\.03536150359121612\ \(0\)\
\-\ follow\\:\\ 0\\.03523894339142475\ \(0\)\
\-\ into\\:\\ 0\\.03474841972557031\ \(0\)\
\-\ can\\:\\ 0\\.034302972826215916\ \(0\)\
\-\ woman\\:\\ 0\\.0340437860547358\ \(0\)\
\-\ exam\\:\\ 0\\.032906204563513744\ \(0\)\
\-\ case\\:\\ 0\\.032840093210261746\ \(0\)\
\-\ large\\:\\ 0\\.03275253389642262\ \(0\)\
\-\ contrast\\:\\ 0\\.03176089998278208\ \(0\)\
\-\ disease\\:\\ 0\\.027439098032376805\ \(0\)\
\-\ be\\:\\ 0\\.026517120400869978\ \(0\)\
\-\ from\\:\\ 0\\.025961335695813173\ \(0\)\
\-\ an\\:\\ 0\\.02499644351446234\ \(0\)\
\-\ are\\:\\ 0\\.02480412328205444\ \(0\)\
\-\ this\\:\\ 0\\.022461567829837662\ \(0\)\
\-\ patient\\:\\ 0\\.021260877595390467\ \(0\)\
